Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clémence Simonin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Advanced Drug Delivery Reviews|November 1, 2005
Embryonic stem cells: meeting the needs for cell therapyMaria Teresa Mitjavila-Garcia, Clémence Simonin, Marc Peschanski
Cells|November 26, 2022
Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative DisordersPasquale Sileo, Clémence Simonin, Patricia Melnyk, et al.
Gait & Posture|May 28, 2011
Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers?Arnaud Delval, Séverine Bleuse, Clémence Simonin, et al.
Parkinsonism & Related Disorders|September 27, 2025
Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)Katia Youssov, Etienne Audureau, Jérémie Pariente, et al.
Plos One|May 27, 2015
Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral graftingLaurent Cleret de Langavant, Sophie Sudraud, Christophe Verny, et al.
Neurobiology of Disease|September 25, 2016
RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson diseaseAurore Nkiliza, Eugénie Mutez, Clémence Simonin, et al.
The Biochemical Journal|September 19, 2019
Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patientsBelén Fernández, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
NPJ Parkinson'S Disease|February 7, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkersJean-Marc Taymans, Eugénie Mutez, William Sibran, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 21, 2010
External globus pallidus stimulation modulates brain connectivity in Huntington's diseaseNoémie Ligot, Pierre Krystkowiak, Clémence Simonin, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|November 1, 2005
Embryonic stem cells: meeting the needs for cell therapyMaria Teresa Mitjavila-Garcia, Clémence Simonin, Marc Peschanski
Cells|November 26, 2022
Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative DisordersPasquale Sileo, Clémence Simonin, Patricia Melnyk, et al.
Gait & Posture|May 28, 2011
Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers?Arnaud Delval, Séverine Bleuse, Clémence Simonin, et al.
Parkinsonism & Related Disorders|September 27, 2025
Comparison of tetrabenazine, tiapride and olanzapine in Huntington's disease: a one-year French randomized multicenter study (Neuro-HD)Katia Youssov, Etienne Audureau, Jérémie Pariente, et al.
Plos One|May 27, 2015
Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral graftingLaurent Cleret de Langavant, Sophie Sudraud, Christophe Verny, et al.
Neurobiology of Disease|September 25, 2016
RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson diseaseAurore Nkiliza, Eugénie Mutez, Clémence Simonin, et al.
The Biochemical Journal|September 19, 2019
Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patientsBelén Fernández, Antonio Jesús Lara Ordóñez, Elena Fdez, et al.
NPJ Parkinson'S Disease|February 7, 2023
Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson's disease and pharmacodynamic biomarkersJean-Marc Taymans, Eugénie Mutez, William Sibran, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 21, 2010
External globus pallidus stimulation modulates brain connectivity in Huntington's diseaseNoémie Ligot, Pierre Krystkowiak, Clémence Simonin, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Pageof 2